Treatsoul Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.17 M
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.99 M
- Satisfied Charges ₹ 0.79 M
About Treatsoul Pharmaceuticals
Treatsoul Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 2023 (One year and 11 months 8 days old ). Its registered office is in Banaskantha, Gujarat, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹0.99 M. The company has closed loans amounting to ₹0.79 M, as per Ministry of Corporate Affairs (MCA) records.
Pinkiben Chaudhary and Savankumar Chaudhary serve as directors at the Company.
Company Details
- Location
Banaskantha, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497GJ2023PTC139263
- Company No.
139263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2023
- Date of AGM
06 Dec 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Who are the key members and board of directors at Treatsoul Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pinkiben Chaudhary  | Director | 17-Mar-2023 | Current |
| Savankumar Chaudhary | Director | 17-Mar-2023 | Current |
Financial Performance of Treatsoul Pharmaceuticals.
Enhance accessibility to Treatsoul Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Treatsoul Pharmaceuticals?
Unlock access to Treatsoul Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.99 M
₹0.79 M
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2023 | Others | ₹0.99 M | Open |
| 11 Oct 2023 | Others | ₹0.79 M | Satisfied |
How Many Employees Work at Treatsoul Pharmaceuticals?
Unlock and access historical data on people associated with Treatsoul Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Treatsoul Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Treatsoul Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.